Acurx Pharmaceuticals/$ACXP
Acurx Pharmaceuticals shares are trading higher after the company announced promising results from its collaboration with Leiden University Medical Center on DNA pol IIIC inhibitors at a scientific conference.
7 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Acurx Pharmaceuticals
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
Ticker
$ACXP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
4
ISIN
US00510M1045
Website
ACXP Metrics
BasicAdvanced
$8.1M
-
-$0.69
-1.37
-
Price and volume
Market cap
$8.1M
Beta
-1.37
52-week high
$0.73
52-week low
$0.30
Average daily volume
191K
Financial strength
Current ratio
1.927
Quick ratio
1.862
Management effectiveness
Return on assets (TTM)
-106.67%
Return on equity (TTM)
-285.79%
Valuation
Price to book
3.36
Price to tangible book (TTM)
3.36
Price to free cash flow (TTM)
-0.641
Growth
Earnings per share change (TTM)
-41.74%
3-year earnings per share growth (CAGR)
-22.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Acurx Pharmaceuticals stock?
Acurx Pharmaceuticals (ACXP) has a market cap of $8.1M as of June 09, 2025.
What is the P/E ratio for Acurx Pharmaceuticals stock?
The price to earnings (P/E) ratio for Acurx Pharmaceuticals (ACXP) stock is 0 as of June 09, 2025.
Does Acurx Pharmaceuticals stock pay dividends?
No, Acurx Pharmaceuticals (ACXP) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next Acurx Pharmaceuticals dividend payment date?
Acurx Pharmaceuticals (ACXP) stock does not pay dividends to its shareholders.
What is the beta indicator for Acurx Pharmaceuticals?
Acurx Pharmaceuticals (ACXP) has a beta rating of -1.37. This means that it has an inverse relation to market volatility.